We have recently demonstrated that TNBC are uniquely capable of expressing IL1β due to aberrant activation of the Notch developmental signaling pathway, resulting in the recruitment of TAMs to the cancer, a reduction in activated CTLs, and cancer progression8,9. The gene discussed is IL1B; the disease is cancer.